4/A: Zura Bio Ltd: Director Corrects Transaction Code in Amended SEC Filing

Someit Sidhu, a director of Zura Bio Ltd, filed an amendment to a previous Form 4 to correct the transaction code for shares acquired in a private placement.

Summary

• Someit Sidhu, a director of Zura Bio Ltd, filed an amended Form 4 with the SEC on September 6, 2024.
• The amendment corrects an administrative error in the original filing from April 24, 2024, which incorrectly stated the transaction code.
• The correct transaction code for the acquisition of 1,186,901 Class A ordinary shares on April 22, 2024, is 'A' (acquisition) instead of 'P'.
• The shares were acquired through a private placement transaction with Pegasus LLC, as per the Securities Purchase Agreement dated April 18, 2024, at a price of $3.13 per share.
• Sidhu is the sole member and beneficial owner of Pegasus LLC.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.

Related Party Transactions

• The transaction involves Pegasus LLC, of which Someit Sidhu, the reporting person, is the sole member and beneficial owner.

Stakeholder Impact

• The correction of the transaction code ensures accurate reporting to shareholders and the public.

Key Dates